Skip to main content
. 2017 Mar 13;8(17):28641–28649. doi: 10.18632/oncotarget.16162

Figure 3. Flow diagram of the study population.

Figure 3

CHB, chronic hepatitis B; NAFLD, non-alcoholic fatty liver disease; HCV, hepatitis C virus; HDV, hepatitis D virus; HIV, human immunodeficiency virus.